Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2013

Open Access 01-12-2013 | Reviewer acknowledgement

Radiation Oncology reviewer acknowledgment 2012

Author: Claus Belka

Published in: Radiation Oncology | Issue 1/2013

Login to get access

Contributing reviewers

The editor of Radiation Oncology would like to thank all our reviewers who have contributed to the journal in Volume 7 (2012).
Metadata
Title
Radiation Oncology reviewer acknowledgment 2012
Author
Claus Belka
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2013
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-8-63

Other articles of this Issue 1/2013

Radiation Oncology 1/2013 Go to the issue

Research

Measurement of skin and target dose in post-mastectomy radiotherapy using 4 and 6 MV photon beams

Research

Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century

Research

Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy

Short report

A multi-national report on methods for institutional credentialing for spine radiosurgery

Research

Robotic radiosurgery versus micro-multileaf collimator: a dosimetric comparison for large or critically located arteriovenous malformations

Research

Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras